SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
▸ About Us ▸ Corporate Social Responsibility ▸ COVID- 19 Relief
It was not just our healthcare programs that persisted through lockdowns. In a bid to support the government infrastructure, Syngene committed a significant part of its CSR contribution towards setting up an ICMR-approved lab that would conduct RT-PCR tests for the Government of Karnataka. Approximately 357,000 RT-PCR tests have been completed for the Government of Karnataka (this figure includes employees and their families tested).
© 2023. Syngene International Limited
We use cookies to improve your experience on our site and show you information relevant to your requirements.
To find out more, read our Privacy Policy and Cookies Policy.